These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 32151194)
1. The effect of CASP3 rs4647610 and rs4647602 polymorphisms on tumour size and cancer stage in papillary thyroid carcinoma. Heidari Z; Eskandari M; Aryan A; Rostamzad F; Salimi S Br J Biomed Sci; 2020 Jul; 77(3):129-134. PubMed ID: 32151194 [TBL] [Abstract][Full Text] [Related]
2. The effect of TP53 and P21 gene polymorphisms on papillary thyroid carcinoma susceptibility and clinical/pathological features. Heidari Z; Harati-Sadegh M; Arian A; Maruei-Milan R; Salimi S IUBMB Life; 2020 May; 72(5):922-930. PubMed ID: 31895498 [TBL] [Abstract][Full Text] [Related]
3. Role of MDM2 309T>G (rs2279744) and I/D (rs3730485) polymorphisms and haplotypes in risk of papillary thyroid carcinoma, tumor stage, tumor size, and early onset of tumor: A case control study. Maruei-Milan R; Heidari Z; Salimi S J Cell Physiol; 2019 Aug; 234(8):12934-12940. PubMed ID: 30548972 [TBL] [Abstract][Full Text] [Related]
4. Polymorphisms in selected DNA repair genes and cell cycle regulating genes involved in the risk of papillary thyroid carcinoma. Halkova T; Dvorakova S; Sykorova V; Vaclavikova E; Vcelak J; Vlcek P; Sykorova P; Kodetova D; Betka J; Lastuvka P; Bavor P; Hoch J; Katra R; Bendlova B Cancer Biomark; 2016 Jun; 17(1):97-106. PubMed ID: 27314298 [TBL] [Abstract][Full Text] [Related]
5. The effects of the genetic polymorphisms of antioxidant enzymes on susceptibility to papillary thyroid carcinoma. Salimi S; Harati-Sadegh M; Eskandari M; Heidari Z IUBMB Life; 2020 May; 72(5):1045-1053. PubMed ID: 32031754 [TBL] [Abstract][Full Text] [Related]
6. Association between single nucleotide polymorphisms of upstream transcription factor 1 (USF1) and susceptibility to papillary thyroid cancer. Yuan Q; Bu Q; Li G; Zhang J; Cui T; Zhu R; Mu D Clin Endocrinol (Oxf); 2016 Apr; 84(4):564-70. PubMed ID: 26052935 [TBL] [Abstract][Full Text] [Related]
7. MMP-9-1562 C/T single nucleotide polymorphism associates with increased MMP-9 level and activity during papillary thyroid carcinoma progression. Roncevic J; Djoric I; Selemetjev S; Jankovic J; Dencic TI; Bozic V; Cvejic D Pathology; 2019 Jan; 51(1):55-61. PubMed ID: 30497805 [TBL] [Abstract][Full Text] [Related]
8. The endothelin 1 and endothelin receptor A gene polymorphisms increase the risk of developing papillary thyroid cancer. Aydin AF; Vural P; Doğru-Abbasoğlu S; Çil E Mol Biol Rep; 2019 Feb; 46(1):199-205. PubMed ID: 30411193 [TBL] [Abstract][Full Text] [Related]
9. Interleukin-10-1082 gene polymorphism is associated with papillary thyroid cancer. Çil E; Kumral A; Kanmaz-Özer M; Vural P; Doğru-Abbasoğlu S; Altuntaş Y; Uysal M Mol Biol Rep; 2014 May; 41(5):3091-7. PubMed ID: 24464184 [TBL] [Abstract][Full Text] [Related]
10. Associations between promoter polymorphism -106A/G of interleukin-11 receptor alpha and papillary thyroid cancer in Korean population. Eun YG; Shin IH; Kim MJ; Chung JH; Song JY; Kwon KH Surgery; 2012 Feb; 151(2):323-9. PubMed ID: 21982075 [TBL] [Abstract][Full Text] [Related]
11. Association between Genetic Polymorphisms in microRNA Machinery Genes and Risk of Papillary Thyroid Carcinoma. Mohammadpour-Gharehbagh A; Heidari Z; Eskandari M; Aryan A; Salimi S Pathol Oncol Res; 2020 Apr; 26(2):1235-1241. PubMed ID: 31250375 [TBL] [Abstract][Full Text] [Related]
12. Association between x-ray repair cross-complementing group 3 (XRCC3) genetic polymorphisms and papillary thyroid cancer susceptibility in a Chinese Han population. Yuan K; Huo M; Sun Y; Wu H; Chen H; Wang Y; Fu R Tumour Biol; 2016 Jan; 37(1):979-87. PubMed ID: 26264616 [TBL] [Abstract][Full Text] [Related]
13. Association between CTLA-4 + 49A > G and - 318C > T single-nucleotide polymorphisms and susceptibility to thyroid neoplasm. Abtahi S; Izadi Jahromi F; Dabbaghmanesh MH; Malekzadeh M; Ghaderi A Endocrine; 2018 Oct; 62(1):159-165. PubMed ID: 30078171 [TBL] [Abstract][Full Text] [Related]
14. CASP3 genetic variants and susceptibility to atrial fibrillation in Chinese Han population. Luo Z; Yan C; Yu P; Bao W; Shen X; Zheng W; Lin X; Wang Z; Chen H; Chen F; Liu D; Huang M Int J Cardiol; 2015 Mar; 183():1-5. PubMed ID: 25662045 [TBL] [Abstract][Full Text] [Related]
15. Association between a promoter polymorphism (rs2192752, -1028A/C) of interleukin 1 receptor, type I (IL1R1) and location of papillary thyroid carcinoma in a Korean population. Park SW; Kim MK; Kwon KH; Kim J Int J Immunogenet; 2012 Dec; 39(6):501-7. PubMed ID: 22594576 [TBL] [Abstract][Full Text] [Related]
16. Single nucleotide polymorphisms of the Fas gene are associated with papillary thyroid cancer. Eun YG; Lee YC; Kim SK; Chung JH; Kwon KH; Park IS Auris Nasus Larynx; 2015 Aug; 42(4):326-31. PubMed ID: 25824544 [TBL] [Abstract][Full Text] [Related]
17. Fine mapping of 14q13 reveals novel variants associated with different histological subtypes of papillary thyroid carcinoma. Jendrzejewski J; Liyanarachchi S; Eiterman A; Thomas A; He H; Nagy R; Senter L; Sworczak K; de la Chapelle A Int J Cancer; 2019 Feb; 144(3):503-512. PubMed ID: 30350351 [TBL] [Abstract][Full Text] [Related]
18. Polymorphisms of the Highly Expressed IL-6 Gene in the Papillary Thyroid Cancer Susceptibility Among Chinese. Li H; Dai H; Li H; Li B; Shao Y Curr Mol Med; 2019; 19(6):443-451. PubMed ID: 31288714 [TBL] [Abstract][Full Text] [Related]
19. Association between microRNA polymorphisms and papillary thyroid cancer susceptibility. Dong G; Zhang R; Xu J; Guo Y Int J Clin Exp Pathol; 2015; 8(10):13450-7. PubMed ID: 26722556 [TBL] [Abstract][Full Text] [Related]
20. [Association of CASP3 polymorphisms and its haplotypes with susceptibility of breast cancer]. Ni Q; Liu B; Jin MJ; Ma XY; Yao KY; Li QL; Chen K Zhejiang Da Xue Xue Bao Yi Xue Ban; 2011 May; 40(3):259-64. PubMed ID: 21671484 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]